3D colonoscopy may sharpen cancer detection
NCT ID NCT07619248
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a new 3D colonoscopy with the standard 2D version to see which more accurately identifies polyps that could become colorectal cancer. About 600 adults undergoing colonoscopy will have their polyps examined with both methods, and the results will be checked against lab tests. The goal is to improve early detection and avoid unnecessary procedures.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 600 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
May 2026
An estimate. Start dates often move.
- Expected to finish
-
May 2027
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Patients aged 18 years or older. * Patients who meet the indications for undergoing colonoscopy. Exclusion Criteria: * Patients younger than 18 years of age or those with contraindications precluding them from undergoing a colonoscopy. (Contraindications for colonoscopy: patients with a recent history of myocardial infarction, pulmonary embolism, cerebrovascular infarction, severe unstable cardiovascular disease, acute abdominal inflammation combined with peritonitis, fulminant colitis, acute diverticulitis, colonic perforation, or toxic megacolon). * Patients with familial hereditary colorectal cancer or colonic polyposis syndromes. * Patients with inflammatory bowel disease (IBD). * Subjects who are unable to complete the colonoscopy or those with poor bowel preparation. * Subjects who are unable to confirm the date of their previous colonoscopy.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Colo-rectal polyps are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Warm water may make colonoscopy less painful for older adults
- Can one number judge colonoscopy quality for every patient?
- Could a belly belt make colonoscopy easier on everyone?
- Flushing the right colon Mid-Procedure: a new way to catch hidden polyps?
- Can an AI coach on your phone get your gut ready for colonoscopy?
- New bowel preps face off against standard solution in phase 3 trial